How many grams of carbohydrates will a patient receiving D5 (Dextrose 5%) at 100ml/hr infusion rate get in 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Carbohydrate Delivery from D5 at 100ml/hr

A patient receiving D5 (5% dextrose) at 100ml/hr will receive 120 grams of carbohydrates in 24 hours.

Calculation

  • D5 contains 5 grams of dextrose per 100 mL 1
  • At 100 mL/hr for 24 hours, the total volume infused is 2,400 mL 2
  • Total carbohydrate delivery: (2,400 mL ÷ 100 mL) × 5 grams = 120 grams of dextrose in 24 hours 1

Clinical Context and Adequacy

This amount represents inadequate nutritional support for most patients:

  • The 120 grams of dextrose provides approximately 480 kcal per 24 hours (dextrose provides ~4 kcal/gram), which is insufficient as sole nutrition 1
  • Critically ill patients should receive 200-300 grams of dextrose per day as part of their nutritional regimen, making this infusion only 40-60% of recommended carbohydrate intake 1, 2
  • For a 70 kg patient, recommended carbohydrate intake is 3.0-3.5 g/kg/day (210-245 grams), meaning this D5 infusion provides only about 49-57% of recommended intake 1

Insulin Coverage Considerations

  • Using the guideline of 1 unit of insulin per 10-15 grams of carbohydrate, a patient with diabetes would require approximately 8-12 units of insulin per 24 hours for nutritional coverage of this dextrose load 1, 2

Important Clinical Caveats

  • This rate of D5 administration is typically used for medication vehicle/dilution or temporary glucose provision while awaiting enteral nutrition, rather than primary nutritional support 2
  • Blood glucose should be monitored every 1-2 hours when administering dextrose-containing fluids 2, 3
  • Thiamine should be administered prior to starting glucose infusion to reduce risk of Wernicke's encephalopathy 1, 2
  • Glucose-containing solutions like D5W should be avoided in acute ischemic stroke patients in the emergency department, as glucose can have detrimental effects in acute brain injury 4

References

Guideline

Dextrose Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Carbohydrate Delivery and Nutritional Support

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

D10 Infusion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

After increasing the D10W (10% dextrose in water) infusion from 40 mL/hr to 60 mL/hr, what monitoring and management steps are recommended?
In an adult patient who is NPO, at what capillary blood glucose level should 50% dextrose (D50W) be administered?
What are the guidelines for using D5 (Dextrose 5%) infusion in patients?
How many carbohydrates per hour is a patient receiving with D5 (5% dextrose solution) at 100ml/hr?
Is it safe to stop D5 1/2 (5% dextrose in 0.5% saline) infusion since I am already receiving free water flushes?
What is the approach to a 16-year-old male with significantly elevated alkaline phosphatase (ALP) levels?
What does the RNFL (Retinal Nerve Fiber Layer) thinning in my OCT (Optical Coherence Tomography) report indicate for my vision, given my history of high myopia and normal intraocular pressures?
What is the appropriate treatment for a child with an abscess on the buttock, considering the use of Amoxicillin-Clavulanate (Amox CV)?
What is the recommended post-exposure prophylaxis (PEP) for a patient with Type 2 Diabetes Mellitus (DM) and a history of previous full vaccination against rabies, who has had a new Category III rabies exposure, considering their immunocompromised status?
What strategies can be used to manage POTS symptoms during air travel, considering emotional stress and physical challenges?
Can a patient with ulcerative colitis (UC) use omega 3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as a treatment option?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.